TNGX
Tango Therapeutics, Inc. · Healthcare
Third Rock Ventures Iv, L.P. sold $2.8M of Tango Therapeutics, Inc.
10% owner
Sold$2,835,368
$9.95Price
285,000Shares
−2%Stake
What TNGX did after the filing
- The stock from Tue, Aug 20 close, $11.11
- −36.6%
- S&P 500, same days
- +2.1%
Measured over 30 trading days, to the Oct 2 close.
Traded Fri, Aug 16. Filed Tue, Aug 20, 1:59 PM ET, during the session. Returns use the Aug 20 close and the Oct 2 close. Not investment advice.